Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0034186 (
pyelonephritis
)
6,144
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Secondary amyloidosis
is a relatively common pathology in which chronic infectious diseases are common causes, especially infected bronchiectasis, osteomyelitis or chronic ulcers. The association of xanthogranulomatous
pyelonephritis
and systemic amyloidosis is extremely rare. To our knowledge, despite innumerable cases of xanthogranulomatous
pyelonephritis
reported in the literature, this association has been reported in only 8 previous cases. Patients usually complain of fever, back or flank pain and urinary tract symptoms. A long lasting evolution of the process is frequent. We report a 70 year old patient who developed amyloidosis secondary to xanthogranulomatous
pyelonephritis
. As well as the rarity of this association, this case is exceptional in its clinical presentation, without any urinary tract symptoms that could suggest the diagnosis.
...
PMID:[Systemic amyloidosis secondary to xanthogranulomatous pyelonephritis]. 1179 22
Rheumatoid arthritis (RA) is a systemic autoimmune disease that is characterized by chronic synovial inflammation. Patients with RA have increased risk of infection; this is related to RA itself or the adverse effects of medication. In this report, we describe a case of emphysematous
pyelonephritis
in a patient with RA associated with
AA amyloidosis
and steroid-induced diabetes mellitus who was taking corticosteroid and low-dose methotrexate.
...
PMID:A case of emphysematous pyelonephritis in a patient with rheumatoid arthritis taking corticosteroid and low-dose methotrexate. 2053 5
AA amyloidosis
is a disorder characterized by the abnormal formation, accumulation and systemic deposition of fibrillary material that frequently involves the kidney. Recurrent
AA amyloidosis
in the renal allograft has been documented in patients with tuberculosis, familial Mediterranean fever, ankylosing spondylitis, chronic
pyelonephritis
and rheumatoid arthritis. De novo
AA amyloidosis
is rarely described. We report two cases of
AA amyloidosis
in the renal allograft. Our first case is a 47-year-old male with a history of ankylosing spondylitis who developed end-stage renal disease reportedly from tubulointerstitial nephritis from non-steroidal anti-inflammatory agent use. A biopsy was never performed. One year after transplantation,
AA amyloidosis
was identified in the femoral head and 8 years post-transplantation,
AA amyloidosis
was identified in the renal allograft. He was treated with colchicine and adalimumab and has stable renal function at 1 year-follow-up. Our second case is a 57-year-old male with a long history of intravenous drug use and hepatitis C infection who developed end-stage kidney disease due to
AA amyloidosis
. Our second patient's course was complicated by renal adenovirus, pulmonary aspergillosis and hepatitis C with
AA amyloidosis
subsequently being identified in the allograft 2.5 years post-transplantation. Renal allograft function remains stable 4-years post-transplantation. These reports describe clinical and pathologic features of two cases of
AA amyloidosis
presenting with proteinuria and focal involvement of the renal allograft.
...
PMID:AA amyloidosis in the renal allograft: a report of two cases and review of the literature. 2283 8
Systemic
AA amyloidosis
is a serious complication of many chronic inflammatory disorders and chronic infections. Renal involvement is seen in the majority of the patients and can lead to end-stage renal disease. Renal transplantation can be performed in these patients; however, amyloidosis can recur in the transplanted kidneys. On the other hand, de novo
AA amyloidosis
in renal transplant patients has been rarely reported. We report a 17-yr-old patient with end-stage renal disease due to genitourinary anomalies who developed recurrent
pyelonephritis
after transplantation. Three yr after transplantation, renal biopsy was performed for proteinuria and
AA amyloidosis
was identified in the renal allograft. Although rare, chronic infections might cause de novo amyloidosis in renal transplant patients. Therefore, amyloidosis should be kept in mind in those types of patients who present with proteinuria.
...
PMID:De novo amyloidosis in a renal transplant patient. 2517 45